Đang chuẩn bị liên kết để tải về tài liệu:
Anti-tumor activity and pharmacokinetics of AP25-Fc fusion protein

AP25 is an anti-tumor peptide with a high affinity for integrins. It exerts its anti-tumor activity by inhibiting angiogenesis and by directly inhibiting the growth of tumor cells. Its half-life time in vivo is only about 50 minutes, which limits its clinical application. | Anti-tumor activity and pharmacokinetics of AP25-Fc fusion protein